New Types of Tests That Can Change Healthcare

Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...
Le Lézard

Natera Presents Updated Analyses From ALTAIR Clinical Trial at ASCO GI

Natera, Inc. , a global leader in cell-free DNA and precision medicine, today announced that new data from the ALTAIR trial will be presented at the 2026 American Society of Clinical Oncology ...